These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 6012478)

  • 1. [Treatment of parkinsonism and other extrapyramidal syndromes with a new thioxanthene derivative, Tremaril, as evaluated using Schwab's Parkinson Evaluation Sheet].
    Goto A; Watanabe T; Aoki T; Sugita T; Narabayashi H
    No To Shinkei; 1966 Jun; 18(6):645-53. PubMed ID: 6012478
    [No Abstract]   [Full Text] [Related]  

  • 2. [Action of amantadine in extrapyramidal syndromes caused by neuroleptics].
    Fanali A; Nardini M; Sorgona F
    Sist Nerv; 1970; 22(5):273-85. PubMed ID: 5514245
    [No Abstract]   [Full Text] [Related]  

  • 3. [Electroclinical manifestations of generalized epilepsy after unilateral thalamotomy for extrapyramidal syndromes].
    Bricolo A; Da Pian R; Perbellini D; Dalle Ore G
    Minerva Neurochir; 1966; 10(4):369-74. PubMed ID: 5997215
    [No Abstract]   [Full Text] [Related]  

  • 4. Troxonium tosylate in the treatment of drug-induced extrapyramidal manifestations.
    Koh CV; Ananth JV; Ban TA; Lehmann HE
    Int Z Klin Pharmakol Ther Toxikol; 1971 Apr; 4(3):289-91. PubMed ID: 4931413
    [No Abstract]   [Full Text] [Related]  

  • 5. Troxonium tosylate in drug-induced Parkinsonism: a controlled comparative study.
    Pecknold JC; Ananth JV; Ban TA; Lehmann HE
    J Clin Pharmacol New Drugs; 1971; 11(5):367-70. PubMed ID: 4998432
    [No Abstract]   [Full Text] [Related]  

  • 6. Neutralization of extrapyramidal side-effects with Methixene.
    Maller O; Heller S
    Dis Nerv Syst; 1971 Jun; 32(6):409-15. PubMed ID: 5570695
    [No Abstract]   [Full Text] [Related]  

  • 7. New and OLD DRUGS FOR PARKINSONISM.
    Med Lett Drugs Ther; 1968 Sep; 10(18):69-72. PubMed ID: 5730145
    [No Abstract]   [Full Text] [Related]  

  • 8. [Metabolic changes in extrapyramidal syndromes and preliminary therapeutic consequences].
    Bruck J; Gerstenbrand Gründig E; Prosenz P
    Fortschr Neurol Psychiatr Grenzgeb; 1965 Dec; 33(12):677-91. PubMed ID: 5178727
    [No Abstract]   [Full Text] [Related]  

  • 9. [Experiences in the treatment of Parkinsonism with L-dopa. IV. Effects on the experimental extrapyranidal brady-akinesia in cats].
    Bergamini L; Bonzanino O; Brignolio F; Fabiani A; Fariello R; Mombelli AM; Mutani R; Pisani W; Postir A; Quattroccolo G; Riccio A; Sabbatini F; Sandigliano G; Schiffer D
    Riv Patol Nerv Ment; 1970 Feb; 91(1):62-6. PubMed ID: 5524934
    [No Abstract]   [Full Text] [Related]  

  • 10. [Long-acting antiparkinson agents. I. Pilot study on benzetimide (342 cases)].
    Korn M; Pinchard A; Breulet M; Goffioul F; Bobon J
    Acta Psychiatr Belg; 1971 Mar; 71(2):65-75. PubMed ID: 5560276
    [No Abstract]   [Full Text] [Related]  

  • 11. [Tremaril in the treatment of parkinsonism].
    Kuran W
    Neurol Neurochir Pol; 1975; 9(2):287-8. PubMed ID: 1153061
    [No Abstract]   [Full Text] [Related]  

  • 12. [Phenomenology of the most important pyramidal and extrapyramidal motoric syndromes. Indications for surgery and results. II].
    Mundinger F
    Z Allgemeinmed; 1974 Jun; 50(18):838-45. PubMed ID: 4410386
    [No Abstract]   [Full Text] [Related]  

  • 13. [Naphthydrofuryl in neurology].
    Ahumada BH
    Prensa Med Argent; 1971 Jul; 58(21):1067-70. PubMed ID: 5096690
    [No Abstract]   [Full Text] [Related]  

  • 14. Diminution of phenethylamine in the urine of Parkinson patients.
    Heller B; Fischer E
    Arzneimittelforschung; 1973 Jun; 23(6):884-6. PubMed ID: 4740778
    [No Abstract]   [Full Text] [Related]  

  • 15. [Results of stereotaxic operations in extrapyramidal movement disorders].
    Bettag W
    Beitr Neurochir; 1966; 13():207-18. PubMed ID: 5341078
    [No Abstract]   [Full Text] [Related]  

  • 16. Alpha and gamma motor systems in extrapyramidal diseases.
    Aranda CL; Rocamora RG; Asenjo GA; Chiorino RR; Donoso P
    Neurocirugia; 1965; 23(1):103-5. PubMed ID: 5877376
    [No Abstract]   [Full Text] [Related]  

  • 17. [Treatment of disturbances of extrapyramidal system with methixene hydrochloride].
    Kuromaru S; Funasaka K; Shuta K
    No To Shinkei; 1969 Nov; 21(11):1301-9. PubMed ID: 5394922
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effect of dioxyphenylalanine (L-DOPA) on extrapyramidal motoric hyperkineses after prolonged neuroleptic therapy].
    Hippius H; Logemann G
    Arzneimittelforschung; 1970 Jul; 20(7):894-6. PubMed ID: 5536051
    [No Abstract]   [Full Text] [Related]  

  • 19. [Experiences with the use of 1-nortricyclenyl-1-phenyl-3-piperidino-1-propanol HC1 (isomer mixture)--P 259--VEB Fahlberg List Magdeburg in the treatment of severe disorders of the extrapyramidal motor system].
    Lange E; Seidel K; Niedermeyer K; Poppe W
    Dtsch Gesundheitsw; 1966 Feb; 21(8):380-3. PubMed ID: 5968216
    [No Abstract]   [Full Text] [Related]  

  • 20. [Persisting extrapyramidal syndrome following neuroleptic therapy].
    Nehlil J
    Rev Neurol (Paris); 1969 Apr; 120(4):270-1. PubMed ID: 5343622
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.